Johnson & Johnson Janssen COVID-19 Vaccine from Japan
Janssen single-dose adenovirus type 26 COVID-19 vaccine for adults. Its immunological profile and retail packaging fit HTS 3002.15.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Single-dose only; wastage minimization strategies
• 2-8°C multi-month stability; emergency use authorizations
• Vector shedding studies for containment